JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.3B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.64B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.55B |
| 4 |
iShares MBS ETF
MBB
|
+$1.29B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
CVS Health
CVS
|
+$676M |
| 3 |
Johnson & Johnson
JNJ
|
+$669M |
| 4 |
Mondelez International
MDLZ
|
+$593M |
| 5 |
UnitedHealth
UNH
|
+$572M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.25% |
| 2 | Technology | 12.49% |
| 3 | Financials | 12.17% |
| 4 | Healthcare | 9.9% |
| 5 | Consumer Discretionary | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4551
Viking Therapeutics
VKTX
$3.68B
| $148K | ﹤0.01% |
14,841
-479
| -3% | -$4.01K |
2018 Q2
3 quarters
|
|
4552
Willis Lease Finance
WLFC
$906M
| $148K | ﹤0.01% |
10,485
-2,238
| -18% | -$29.7K |
2017 Q4
5 quarters
|
|
|
CDTX
4553
DELISTED
Cidara Therapeutics
CDTX
| $147K | ﹤0.01% |
2,772
-3,620
| -57% | -$198K |
2016 Q1
12 quarters
|
|
4554
Weis Markets
WMK
$1.83B
| $147K | ﹤0.01% |
3,594
-110
| -3% | -$5.17K |
2015 Q4
13 quarters
|
|
|
PCSB
4555
DELISTED
PCSB Financial Corporation
PCSB
| $147K | ﹤0.01% |
7,530
+3,294
| +78% | +$66.1K |
2017 Q2
7 quarters
|
|
4556
Schwab Fundamental US Small Company Index ETF
FNDA
$8.83B
| $146K | ﹤0.01% |
7,854
-132,042
| -94% | -$2.42M |
2018 Q2
3 quarters
|
|
4557
Titan International
TWI
$451M
| $146K | ﹤0.01% |
24,553
-194,473
| -89% | -$1.1M |
2015 Q4
13 quarters
|
|
|
LGF.B
4558
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $146K | ﹤0.01% |
9,620
-35,101
| -78% | -$551K |
2016 Q4
9 quarters
|
|
|
CHUY
4559
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $146K | ﹤0.01% |
6,372
+60
| +1% | +$1.31K |
2016 Q3
10 quarters
|
|
|
RWGV
4560
DELISTED
Direxion Russell 1000 Growth Over Value ETF
RWGV
| $146K | ﹤0.01% |
+2,600
| New | +$139K |
2019 Q1
0 quarters
|
|
|
CEMI
4561
DELISTED
Chembio diagnostics, Inc.
CEMI
| $146K | ﹤0.01% |
26,395
+1,072
| +4% | +$6.96K |
2018 Q4
1 quarter
|
|
4562
Horizon Bancorp
HBNC
$988M
| $145K | ﹤0.01% |
9,034
-425
| -4% | -$7.12K |
2017 Q4
5 quarters
|
|
4563
Origin Bancorp
OBK
$1.64B
| $145K | ﹤0.01% |
4,261
-1,483
| -26% | -$51.6K |
2018 Q2
3 quarters
|
|
4564
CorVel
CRVL
$3.84B
| $142K | ﹤0.01% |
6,531
-426
| -6% | -$9.1K |
2015 Q4
13 quarters
|
|
4565
Invesco Zacks Mid-Cap ETF
CZA
$171M
| $142K | ﹤0.01% |
2,091
-192
| -8% | -$12.5K |
2016 Q4
9 quarters
|
|
4566
Tredegar Corp
TG
$244M
| $142K | ﹤0.01% |
8,809
-18
| -0.2% | -$305 |
2013 Q2
23 quarters
|
|
|
NESR
4567
National Energy Services Reunited Corp
NESR
$2.43B
| $142K | ﹤0.01% |
+13,604
| New | +$120K |
2019 Q1
0 quarters
|
|
|
SMMF
4568
DELISTED
Summit Financial Group, Inc.
SMMF
| $142K | ﹤0.01% |
5,375
+766
| +17% | +$18.1K |
2017 Q4
5 quarters
|
|
4569
Ingles Markets
IMKTA
$1.64B
| $141K | ﹤0.01% |
5,121
-3,583
| -41% | -$105K |
2015 Q1
16 quarters
|
|
4570
Star Group
SGU
$423M
| $141K | ﹤0.01% |
+14,671
| New | +$140K |
2019 Q1
0 quarters
|
|
|
STEL
4571
DELISTED
Stellar Bancorp
STEL
| $141K | ﹤0.01% |
4,343
-2,570
| -37% | -$83K |
2017 Q4
5 quarters
|
|
|
BIMI
4572
DELISTED
BIMI International Medical Inc. Common Stock
BIMI
| $141K | ﹤0.01% |
456
+214
| +88% | +$94.6K |
2018 Q4
1 quarter
|
|
|
ALLK
4573
DELISTED
Allakos
ALLK
| $140K | ﹤0.01% |
3,451
+1,306
| +61% | +$52.8K |
2018 Q3
2 quarters
|
|
4574
Brown-Forman Class A
BF.A
$12.3B
| $140K | ﹤0.01% |
2,739
+672
| +33% | +$32.6K |
2015 Q4
13 quarters
|
|
4575
MeiraGTx Holdings
MGTX
$1.05B
| $140K | ﹤0.01% |
8,118
+6,878
| +555% | +$96.9K |
2018 Q3
2 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2019 Portfolio in Review
As of Q1 2019, JP Morgan Chase held 6,314 positions worth $490B, up 13% from $432B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2019 filing shows 537 new, 2,080 increased, 2,670 reduced and 537 closed positions. Its largest new stake was Lyft: 2,510,596 shares worth $197M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q1 2019 buy was Lyft: 2,510,596 shares worth $197M.
- JP Morgan Chase added most to Vanguard Total International Bond ETF in Q1 2019, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q1 2019 reduction was Apple, cutting an estimated $693M.
- JP Morgan Chase fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $164M.
- JP Morgan Chase's ten largest holdings make up 16% of its $490B portfolio in Q1 2019.
- JP Morgan Chase opened 537 new positions and closed 537 in Q1 2019.
- JP Morgan Chase's portfolio value rose 13% quarter-over-quarter to $490B.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.